These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 30498011)
1. MAGEA1 inhibits the expression of BORIS via increased promoter methylation. Zhao J; Wang Y; Liang Q; Xu Y; Sang J J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30498011 [TBL] [Abstract][Full Text] [Related]
2. DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer. Woloszynska-Read A; James SR; Link PA; Yu J; Odunsi K; Karpf AR Cancer Immun; 2007 Dec; 7():21. PubMed ID: 18095639 [TBL] [Abstract][Full Text] [Related]
3. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage. Woloszynska-Read A; Zhang W; Yu J; Link PA; Mhawech-Fauceglia P; Collamat G; Akers SN; Ostler KR; Godley LA; Odunsi K; Karpf AR Clin Cancer Res; 2011 Apr; 17(8):2170-80. PubMed ID: 21296871 [TBL] [Abstract][Full Text] [Related]
4. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells. Zhao J; Wang Y; Mu C; Xu Y; Sang J Oncogene; 2017 Aug; 36(35):5023-5034. PubMed ID: 28459460 [TBL] [Abstract][Full Text] [Related]
5. BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines. Woloszynska-Read A; James SR; Song C; Jin B; Odunsi K; Karpf AR Cancer Immun; 2010 Jul; 10():6. PubMed ID: 20649179 [TBL] [Abstract][Full Text] [Related]
6. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943 [TBL] [Abstract][Full Text] [Related]
7. CTCF and BORIS-mediated autophagy regulation via alternative splicing of BNIP3L in breast cancer. Pandey A; Kakani P; Shukla S J Biol Chem; 2024 Jul; 300(7):107416. PubMed ID: 38810696 [TBL] [Abstract][Full Text] [Related]
8. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944 [TBL] [Abstract][Full Text] [Related]
9. Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein. Schwarzenbach H; Eichelser C; Steinbach B; Tadewaldt J; Pantel K; Lobanenkov V; Loukinov D BMC Cancer; 2014 Nov; 14():796. PubMed ID: 25363021 [TBL] [Abstract][Full Text] [Related]
11. BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer. Link PA; Zhang W; Odunsi K; Karpf AR Cancer Immun; 2013; 13():6. PubMed ID: 23390377 [TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. Hoivik EA; Kusonmano K; Halle MK; Berg A; Wik E; Werner HM; Petersen K; Oyan AM; Kalland KH; Krakstad C; Trovik J; Widschwendter M; Salvesen HB Oncotarget; 2014 Feb; 5(4):1052-61. PubMed ID: 24658009 [TBL] [Abstract][Full Text] [Related]
13. High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells. Alberti L; Renaud S; Losi L; Leyvraz S; Benhattar J PLoS One; 2014; 9(10):e109921. PubMed ID: 25279549 [TBL] [Abstract][Full Text] [Related]
14. [BORIS Regulates SOCS3 Expression Through Epigenetic Mechanisms in Human Hepatocellular Carcinoma Cells]. He JY; Liu QY; Wei L; Liu ZJ; Huang Y; Yu XQ; Li B; Qin Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):1-7. PubMed ID: 29737080 [TBL] [Abstract][Full Text] [Related]
15. Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors. Renaud S; Pugacheva EM; Delgado MD; Braunschweig R; Abdullaev Z; Loukinov D; Benhattar J; Lobanenkov V Nucleic Acids Res; 2007; 35(21):7372-88. PubMed ID: 17962299 [TBL] [Abstract][Full Text] [Related]
16. BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas. Hines WC; Bazarov AV; Mukhopadhyay R; Yaswen P PLoS One; 2010 Mar; 5(3):e9738. PubMed ID: 20305816 [TBL] [Abstract][Full Text] [Related]
18. Discovering a binary CTCF code with a little help from BORIS. Lobanenkov VV; Zentner GE Nucleus; 2018 Jan; 9(1):33-41. PubMed ID: 29077515 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic hierarchy within the MAGEA1 cancer-germline gene: promoter DNA methylation dictates local histone modifications. Cannuyer J; Loriot A; Parvizi GK; De Smet C PLoS One; 2013; 8(3):e58743. PubMed ID: 23472218 [TBL] [Abstract][Full Text] [Related]
20. The combined action of CTCF and its testis-specific paralog BORIS is essential for spermatogenesis. Rivero-Hinojosa S; Pugacheva EM; Kang S; Méndez-Catalá CF; Kovalchuk AL; Strunnikov AV; Loukinov D; Lee JT; Lobanenkov VV Nat Commun; 2021 Jun; 12(1):3846. PubMed ID: 34158481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]